Member Info for MKopportunist

More excellent news this morning and no doubt a lot more to come over the next few months and years. Just a quick reminder to everyone not to get too carried away in expecting the share price to exhibit a stratospheric straight line rise. There will inevitably be peaks and troughs along the way and, at times, the likely volatility will cause even some strong stomachs to churn occasionally. Having said that, fasten your belts, hold onto your hats, sit tight and enjoy the ride of your lives!

The share price drop over an extended period isn't by any means restricted to, or reliant on, the outcome in respect of the US licence. Many investors have had their patience tested by poor results, with various excuses , and fairly abysmal communication from the company (especially in relation to StoneX) over an extended period; it's hardly surprising that some have decided to call time on continued holding when their capital could be better deployed elsewhere. However, with results coming up in August and with cost reduction steps taken, I happen to think now isn't the time to sell. I certainly don't think long term holders will see a positive return on their holdings any time some, but I can see that there could be some significant reduction in their losses if they continue to hold. For the brave, acquiring more stock, to reduce their overall average cost, makes sense at current levels, as there could easily be some rapid appreciation over the next 2 to 6 months. Just don't bet your house!

The size of any BoD purchase, as with anyone else's purchase, needs to be viewed in relation to their personal position and source of funds. So, for example, I'd be more convinced by a director buying £50k of shares if he'd mortgaged his house to get the money than I would by a casb multimillionaire taking the same investment from his liquid funds.

The lack of sustained reaction to the US Licence may well be that it's no big deal in the eyes of institutional investors, or they don't think the Board can make full use of any opportunities it may have provided, or that it's simply a wait and see scenario.

I think any sustained price movement will only be driven by results, as both institutional and private investors have grown tired of excuses and "pillars for growth" plans/promises and would prefer bread today over jam tomorrow.

Short term, not forgetting results are out comparatively soon, price movements are likely to be driven by private investors/traders taking quick "in & out" profits; do bear in mind it's a very tight free float and price can move surprisingly on quite light trade volumes. Longer term, I believe larger investors will be looking to see concrete financial progress before acquiring stock; existing institutional investors won't be in any rush to throw more money in. There does still remain scope for takeover interest, but that would almost certainly result in institutions being prepared to take a loss. A possibility, that might prove interesting, is following Wise and moving the listing to the US.

For those who would like to remain tax-free in UK, there's also the option of taking your exposure via spread bets rather than holding equity; also allows you to leverage. Not necessarily a recommendation, but something else to consider.

Katstrangler, yes it's certainly worth a punt and I can envisage 70p plus relatively soon as I can see some private investors being willing to throw more money in and the free float being quite small. My personal take is that it is not an investment grade stock and I'm better looking for short term advantages via spread bets on this one, whilst leaving the real money in better quality stocks. I'm not criticising anyone for taking a different approach, that's not my concern, but I would suggest taking a long hard look at the numbers and the personnel before committing any large sums on this one. Having said that, "you pays your money and takes your choice." So best of luck to those prepared to stick with it.

Hello Dave, the management has yet to produce the goods in terms of solid results. At present all we have is a history of failure, excuses and empty promises. I exited as a shareholder above 90 and secured a very modest profit. I remain interested as a trader, via spread bets, but that's all.

Yes, the US Licence has arrived. The question is whether this company's Board is competent enough to make good use of it. Given events of the last couple of years, I still have doubts. I've said before that I view this as an interesting stock from a trading perspective, but not from an investment one, and I've not changed my view. I do expect to see 70p plus fairly soon, simply as some private investors are tempted back in to try and recoup their previous losses.

Some news at last and good news as a bonus. Will probably see a useful short term bounce in share price, but would await results before anyone gets too carried away.

Most acorns don't grow into mighty oaks, but get eaten by squirrels, badgers, mice and so on. Even if it gets to look like a promising sapling there's a good chance deer will get it.

The successful placing is an excellent move and privides a very firm footing to the share price. This may be your very last chance to pick up stock at this price level.

The problem here is a track record of big talk, little action. The target core business area is rapidly evolving and CABP is far from the only player in the game, it simply lacks the expertise and resources to compete successfully and to take full advantage of opportunities as they arise. CABP looks destined to underperform and may simply wither on the vine. The long-standing lack of communication is another factor that hampers any significant price movement.

KnockIutThePin, I have had reservations about the link up with VISA from the outset. In my view it was simply a short term move by VISA to take advantage of some very specific ability to reach niche markets. Once "in", an organisation like VISA will quickly elbow aside the likes of CABP. So, to answer your question, no, I don't think this move by VISA represents any potential for CABP to benefit.

Swaltz, I think you can forget about the US license in the current climate. At today's prices CABP is almost starting to look attractive, but there's still a lot of better opportunities available. Now I'm no longer a shareholder, but taking punts on volatility of this stock via spreadbets, it's becoming more interesting.

In view of some posters' fretting about price movements, take a quote from Warren Buffet,

"When it's raining gold grab a bucket not a thimble."

Camo1997 Yes, but then StoneX looked at the books, the prospects and the management and decided they didn't like the look of any of them and walked away. With the current US trade position th granting of a US license is possibly dead in the water. This business, even now, is probably worth more than the current share price implies, but it will take some major positive news to generate any sustained price increase.

96dc2 You could consider a spread bet instead; leveraged exposure, so greatly magnifying your gain (or loss, of course) and tax-free.

Dps2329, I can't help but think the latest diversification strategy is just the latest in a string of bold plans from successive management bods who actually don't have much of a clue. Not only are the continuing management seeing margins falling, but the diversification process anx progress does not seem to be well managed so far. However, it is now slowly beginning to show some signs of improvement in key markets and the company should be well placed both to reclaim lost ground and then make steady progress. IF we see some markedly better news at the half year, then there's room to suppose a modest re-rating of the stock. At present I think it looks a little on the cheaper side and 60p plus would be reasonable. For me though, overall this is not an investment-grade stock and I continue to view it as a trading play rather than one to hold.

Glowacki, that's the new CFO picking up what could be viewed as an "obligatory" holding. Although the full year's figures weren't great, at least they weren't materially worse than expected. I'm still not convinced about management capability here, but at present the stock is looking on the cheap side and shouldn't take too much to push it back into 60p plus territory.

Cottill, it's basically the middle tier of the US OTC "market". Plenty of details on the Internet for you to find if you wish.